High-throughput continuous evolution of compact Cas9 variants targeting single-nucleotide-pyrimidine PAMs DOI Creative Commons
Tony P. Huang, Zachary Heins, Shannon M. Miller

и другие.

Nature Biotechnology, Год журнала: 2022, Номер 41(1), С. 96 - 107

Опубликована: Сен. 8, 2022

Despite the availability of Cas9 variants with varied protospacer-adjacent motif (PAM) compatibilities, some genomic loci-especially those pyrimidine-rich PAM sequences-remain inaccessible by high-activity proteins. Moreover, broadening sequence compatibility through engineering can increase off-target activity. With directed evolution, we generated four that together enable targeting most sequences in human genome. Using phage-assisted noncontinuous evolution and eVOLVER-supported continuous evolved Nme2Cas9, a compact variant, into recognize single-nucleotide pyrimidine-PAM sequences. We developed general selection strategy requires functional editing fully specified target protospacers PAMs. applied this to evolve eNme2-T.1, eNme2-T.2, eNme2-C eNme2-C.NR. Variants eNme2-T.1 eNme2-T.2 offer access N

Язык: Английский

Drug delivery systems for RNA therapeutics DOI Open Access
Kalina Paunovska, David Loughrey, James E. Dahlman

и другие.

Nature Reviews Genetics, Год журнала: 2022, Номер 23(5), С. 265 - 280

Опубликована: Янв. 4, 2022

Язык: Английский

Процитировано

812

CRISPR technology: A decade of genome editing is only the beginning DOI
Joy Y. Wang, Jennifer A. Doudna

Science, Год журнала: 2023, Номер 379(6629)

Опубликована: Янв. 19, 2023

The advent of clustered regularly interspaced short palindromic repeat (CRISPR) genome editing, coupled with advances in computing and imaging capabilities, has initiated a new era which genetic diseases individual disease susceptibilities are both predictable actionable. Likewise, genes responsible for plant traits can be identified altered quickly, transforming the pace agricultural research breeding. In this Review, we discuss current state CRISPR-mediated manipulation human cells, animals, plants along relevant successes challenges present roadmap future technology.

Язык: Английский

Процитировано

608

High-content CRISPR screening DOI Open Access
Christoph Bock, Paul Datlinger, Florence M. Chardon

и другие.

Nature Reviews Methods Primers, Год журнала: 2022, Номер 2(1)

Опубликована: Фев. 10, 2022

Язык: Английский

Процитировано

371

The CRISPR-Cas toolbox and gene editing technologies DOI Creative Commons

Guanwen Liu,

Qiupeng Lin, Shuai Jin

и другие.

Molecular Cell, Год журнала: 2021, Номер 82(2), С. 333 - 347

Опубликована: Дек. 29, 2021

Язык: Английский

Процитировано

260

Rational combinations of targeted cancer therapies: background, advances and challenges DOI
Haojie Jin, Liqin Wang, René Bernards

и другие.

Nature Reviews Drug Discovery, Год журнала: 2022, Номер 22(3), С. 213 - 234

Опубликована: Дек. 12, 2022

Язык: Английский

Процитировано

246

High-content CRISPR screening DOI
Christoph Bock, Paul Datlinger, Florence M. Chardon

и другие.

Nature Reviews Methods Primers, Год журнала: 2022, Номер 2(1)

Опубликована: Фев. 10, 2022

Язык: Английский

Процитировано

204

CRISPR-based genome editing through the lens of DNA repair DOI Creative Commons

Tarun S. Nambiar,

Lou Baudrier,

Pierre Billon

и другие.

Molecular Cell, Год журнала: 2022, Номер 82(2), С. 348 - 388

Опубликована: Янв. 1, 2022

Язык: Английский

Процитировано

154

Advances in CRISPR therapeutics DOI Open Access

Michael Chavez,

Xinyi Chen,

Paul B. Finn

и другие.

Nature Reviews Nephrology, Год журнала: 2022, Номер 19(1), С. 9 - 22

Опубликована: Окт. 24, 2022

Язык: Английский

Процитировано

112

Adeno-Associated Virus Toolkit to Target Diverse Brain Cells DOI Creative Commons
Rosemary C. Challis, Sripriya Ravindra Kumar, Xinhong Chen

и другие.

Annual Review of Neuroscience, Год журнала: 2022, Номер 45(1), С. 447 - 469

Опубликована: Апрель 20, 2022

Recombinant adeno-associated viruses (AAVs) are commonly used gene delivery vehicles for neuroscience research. They have two engineerable features: the capsid (outer protein shell) and cargo (encapsulated genome). These features can be modified to enhance cell type or tissue tropism control transgene expression, respectively. Several engineered AAV capsids with unique tropisms been identified, including variants enhanced central nervous system transduction, specificity, retrograde transport in neurons. Pairing these AAVs modern regulatory elements state-of-the-art reporter, sensor, effector enables highly specific expression anatomical functional analyses of brain cells circuits. Here, we discuss recent advances that provide a comprehensive (capsid cargo) toolkit genetic access molecularly defined types.

Язык: Английский

Процитировано

98

Multidimensional control of therapeutic human cell function with synthetic gene circuits DOI Open Access

Hui-Shan Li,

Divya V. Israni, Keith A. Gagnon

и другие.

Science, Год журнала: 2022, Номер 378(6625), С. 1227 - 1234

Опубликована: Дек. 15, 2022

Synthetic gene circuits that precisely control human cell function could expand the capabilities of gene- and cell-based therapies. However, platforms for developing in primary cells drive robust functional changes vivo have compositions suitable clinical use are lacking. Here, we developed synthetic zinc finger transcription regulators (synZiFTRs), which compact based largely on human-derived proteins. As a proof principle, engineered switches allow precise, user-defined over therapeutically relevant genes T using orthogonal, US Food Drug Administration-approved small-molecule inducers. Our can instruct to sequentially activate multiple cellular programs such as proliferation antitumor activity synergistic therapeutic responses. This platform should accelerate development translation diverse types contexts.

Язык: Английский

Процитировано

98